Todd Matthew Morgan MD

Minimally Invasive Surgery, Surgical Oncology

Professor, Chief of Urologic Oncology, University of Michigan

Summary

I am a board certified urologic surgeon specializing in the treatment of genitourinary malignancies. Previously at Vanderbilt University, I joined the faculty at the University of Michigan in 2012. I am originally from Seattle, WA, and completed my undergraduate and medical training at Harvard University. I returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for my fellowship training in urological oncology and subsequent faculty appointment at Vanderbilt. My research focuses on understanding the early spread of prostate cancer cells, with the aim of identifying those patients with the most aggressive tumors and developing appropriate therapeutic strategies for these individuals.

Vanderbilt University Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2009 - 2011
University of WashingtonResidency, Urology, 2003 - 2009
University of WashingtonResidency, Surgery, 2003 - 2005
Harvard Medical SchoolClass of 2003
Harvard UniversityAB, 1995 - 1999

Outstanding Reviewer in Prostate Cancer Journal of Urology, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Best Poster American Urological Association, 2011
Best of AUA/JUA Annual Meeting 2011
Gerald P. Murphy Scholar AUA, 2009
International Volunteers in Urology Scholar 2007
Scholar-in-Training Award AACR, 2007
Warren H. Chapman Research Award U. of Washington, 2007
CaPSURE™ Scholar 2007
First Prize Poster Society of Urologic Oncology, 2006
First Prize Resident Paper Northwest Urological Society, 2006
Young Investigator Award Prostate Cancer Foundation
Join now to see all

PubMed

Association between periodontitis severity and prostate-specific antigen levels using the NHANES data.
Muhammad H A Saleh, Khushboo Kalani, Hamoun Sabri, Shahad Alhazmi, Deepthy Nair
Journal of Periodontology. 2025-03-18
Knowledge and Worry Following Review of Standard vs Patient-Centered Pathology Reports.
Cathryn J Lapedis, Sophia R Kurnot, Sarah E Bergholtz, Scott R Owens, Sarah T Hawley
JAMA. 2025-02-25
1 citations
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial.
Todd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, Rodney L Dunn, Udit Singhal
European Urology. 2025-02-01

Journal Articles

Editorial Comment: Initial Extended Transrectal Prostate Biopsy-Are More Prostate Cancers Detected With 18 Cores Than With 12 Cores?
Morgan, T.M. and Corman, J.M., J Urol, 1/1/2008
Osteotomy for malunited fractures of the distal radius: a comparison of structural and nonstructural autogenous bone grafts
Ring D, Roberge C, Morgan T, Jupiter JB, J Hand Surg, 1/1/2002

MRI-Invisible Prostate Lesions: Are They Dangerous?January 9th, 2025
Artera Launches AI Test for Decision-Making on Prostate Cancer Treatment CourseAugust 6th, 2024
Should We Use PSA to Find Active Surveillance Candidates?April 3rd, 2022
Join now to see all

Determining the clinical impact of gene expression testing in localized prostate cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2025
Determining the clinical impact of gene expression testing in localized prostate cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2025
Determining the clinical impact of gene expression testing in localized prostate cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2025